High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement …

The Journal of clinical investigation, 1994 - Am Soc Clin Investig
In patients with dermatomyositis (DM) the earliest lesion is microvasculopathy mediated by
deposition of C5b-C9 membranolytic attack complex (MAC) on intramuscular capillaries …
被引用次数：470 相关文章

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement …

M Basta, MC Dalakas - The Journal of Clinical Investigation, 1994 - europepmc.org
In patients with dermatomyositis (DM) the earliest lesion is microvasculopathy mediated by
deposition of C5b-C9 membranolytic attack complex (MAC) on intramuscular capillaries …

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement …

M Basta, MC Dalakas - Journal of Clinical Investigation, 1994 - ncbi.nlm.nih.gov
In patients with dermatomyositis (DM) the earliest lesion is microvasculopathy mediated by
deposition of C5b-C9 membranolytic attack complex (MAC) on intramuscular capillaries …

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement …

M Basta, MC Dalakas - The Journal of clinical …, 1994 - pubmed.ncbi.nlm.nih.gov
In patients with dermatomyositis (DM) the earliest lesion is microvasculopathy mediated by
deposition of C5b-C9 membranolytic attack complex (MAC) on intramuscular capillaries …

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement …

M Basta, MC Dalakas - Journal of Clinical Investigation, 1994 - hero.epa.gov
In patients with dermatomyositis (DM) the earliest lesion is microvasculopathy mediated by
deposition of C5b-C9 membranolytic attack complex (MAC) on intramuscular capillaries …

[引用][C] High-dose intravenous immunoglobulin exerts its beneficial effect in in patients with dermatomyositis by blosking endomysial deposition of activated …

M BASTA - J Chlin Invest, 1994 - cir.nii.ac.jp
High-dose intravenous immunoglobulin exerts its beneficial effect in in patients with
dermatomyositis by blosking endomysial deposition of activated complementy fragments. | CiNii …
[PDF] academia.edu

[PDF][PDF] Complement Fragments

M Basta, MC Dalakas - 1994 - academia.edu
In patients with dermatomyositis (DM) the earliest lesion is microvasculopathy mediated by
deposition of C5b-C9 membranolytic attack complex (MAC) on intramuscular capillaries …

[引用][C] High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement …

M BASTA - J Clin Invest, 1994 - cir.nii.ac.jp
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with
dermatomyositis by blocking endomysial deposition of activated complement fragments | CiNii …

[引用][C] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN EXERTS ITS BENEFICIAL EFFECT IN PATIENTS WITH DERMATOMYOSITIS BY BLOCKING ENDOMYSIAL …

M BASTA, MC DALAKAS - The Journal of …, 1994 - American Society for Clinical …